Acute Migraine Treatment in Adults
- PMID: 25877672
- DOI: 10.1111/head.12550
Acute Migraine Treatment in Adults
Abstract
There are many options for acute migraine attack treatment, but none is ideal for all patients. This study aims to review current medical office-based acute migraine therapy in adults and provides readers with an organized approach to this important facet of migraine treatment. A general literature review includes a review of several recent published guidelines. Acetaminophen, 4 nonsteroidal anti-inflammatory drugs (NSAIDs) (ibuprofen, acetylsalicylic acid [ASA], naproxen sodium, and diclofenac potassium), and 7 triptans (almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, and zolmitriptan) have good evidence for efficacy and form the core of acute migraine treatment. NSAID-triptan combinations, dihydroergotamine, non-opioid combination analgesics (acetaminophen, ASA, and caffeine), and several anti-emetics (metoclopramide, domperidone, and prochlorperazine) are additional evidence-based options. Opioid containing combination analgesics may be helpful in specific patients, but should not be used routinely. Clinical features to be considered when choosing an acute migraine medication include usual headache intensity, usual rapidity of pain intensity increase, nausea, vomiting, degree of disability, patient response to previously used medications, history of headache recurrence with previous attacks, and the presence of contraindications to specific acute medications. Available acute medications can be organized into 4 treatment strategies, including a strategy for attacks of mild to moderate severity (strategy one: acetaminophen and/or NSAIDs), a triptan strategy for patients with severe attacks and for attacks not responding to strategy one, a refractory attack strategy, and a strategy for patients with contraindications to vasoconstricting drugs. Acute treatment of migraine attacks during pregnancy, lactation, and for patients with chronic migraine is also discussed. In chronic migraine, it is particularly important that medication overuse is eliminated or avoided. Migraine treatment is complex, and treatment must be individualized and tailored to the patient's clinical features. Clinicians should make full use of available medications and formulations in an organized approach.
Keywords: acute; adult; migraine; nonsteroidal anti-inflammatory drug; treatment; triptan.
© 2015 American Headache Society.
Similar articles
-
Acute Migraine Treatment.Continuum (Minneap Minn). 2015 Aug;21(4 Headache):953-72. doi: 10.1212/CON.0000000000000192. Continuum (Minneap Minn). 2015. PMID: 26252584 Review.
-
The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies.Headache. 2015 Jan;55(1):3-20. doi: 10.1111/head.12499. Headache. 2015. PMID: 25600718 Review.
-
Pharmacological synergy: the next frontier on therapeutic advancement for migraine.Headache. 2012 Apr;52(4):636-47. doi: 10.1111/j.1526-4610.2011.02058.x. Epub 2012 Jan 6. Headache. 2012. PMID: 22221151 Review.
-
Canadian Headache Society Guideline: acute drug therapy for migraine headache.Can J Neurol Sci. 2013 Sep;40(5 Suppl 3):S1-S80. Can J Neurol Sci. 2013. PMID: 23968886 Review.
-
Medical Treatment Guidelines for Acute Migraine Attacks.Acta Neurol Taiwan. 2017 Jun 15;26(2):78-96. Acta Neurol Taiwan. 2017. PMID: 29250761
Cited by
-
Which is more effective for the treatment of Acute Migraine Attack: Dexketoprofen, Ibuprofen or Metoclopramide?Pak J Med Sci. 2018 Mar-Apr;34(2):418-423. doi: 10.12669/pjms.342.13815. Pak J Med Sci. 2018. PMID: 29805419 Free PMC article.
-
Do antithrombotic drugs have a role in migraine prevention? A systematic review.Headache. 2025 Apr;65(4):709-727. doi: 10.1111/head.14917. Epub 2025 Feb 24. Headache. 2025. PMID: 39989443 Free PMC article.
-
Nasal spray (Zavegepant) for migraines: a mini-review.Ann Med Surg (Lond). 2023 May 15;85(6):2787-2790. doi: 10.1097/MS9.0000000000000843. eCollection 2023 Jun. Ann Med Surg (Lond). 2023. PMID: 37363553 Free PMC article.
-
Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.Int J Mol Sci. 2021 Mar 10;22(6):2805. doi: 10.3390/ijms22062805. Int J Mol Sci. 2021. PMID: 33802091 Free PMC article. Review.
-
An investigation of the views and practices of Australian community pharmacists on pain and fever management and clinical guidelines.Pharm Pract (Granada). 2019 Apr-Jun;17(2):1436. doi: 10.18549/PharmPract.2019.2.1436. Epub 2019 Jun 11. Pharm Pract (Granada). 2019. PMID: 31275495 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical